✦ LIBER ✦

446 Docetaxel, Carboplatin and Trastuzumab (TCH) as Neoadjuvant (neoadj) Therapy in Patients (pts) with HER2-positive (HER2+) Operable Breast Cancer (BrCa)

✍ Scribed by M. Zuradelli; G. Gullo; J. Walshe; A.M. Defrein; J. Healy; R. Kalachand; H. Murray; F. Sclafani; J.P. Crown

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P304 Docetaxel, carboplatin and weekly t

✍ H.-C. Kolberg; L. Akpolat-Basci; F. Otterbach; A. Drumm; C. Tirier 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 36 KB

Trastuzumab-based neoadjuvant therapy in

✍ Helena R. Chang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 348 KB 👁 2 views

Immunohistochemical expression of HER1,

✍ Kan Yonemori; Koji Tsuta; Chikako Shimizu; Yutaka Hatanaka; Akihiro Hirakawa; Ma 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

Preoperative therapy with trastuzumab an

✍ Monica Iorfida; Vincenzo Bagnardi; Alessandra Balduzzi; Silvia Dellapasqua; Anna 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 155 KB

2129 POSTER An open-label study of capec

✍ D. Tripathy; C. Moisa; S. Glück 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Trastuzumab combined to neoadjuvant chem

✍ Antonis Valachis; Davide Mauri; Nikolaos P. Polyzos; Grigoris Chlouverakis; Dimi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 220 KB